Under the Australian Government’s National Medicines Policy framework, the Department of Health is conducting a Post-market Review of Authority Required PBS listings. The objective of the Review is to improve patient safety and care by reducing red tape and administrative burden for health professionals.

This Review will consider criteria to determine Authority Required listings, and review all Authority Required listings, with the objective of reducing the administrative burden on prescribers and dispensers of PBS listed medicines. The Authority Required listings will be identified and reviewed in groups targeting those that create the greatest regulatory burden with the first priority area being Authority Required listings relating to the use of drugs in cancer.

Terms of Reference

• Review the criteria used by the PBAC to determine if a medicine should be recommended as Authority Required or Authority Required (Streamlined) on the PBS.
• Systematically review the current Authority Required listings according to the proposed criteria to ensure this is applied consistently to all PBS Authority listed medicines.

For more details, go to: http://www.pbs.gov.au/pbs/home